Skip to main content

Acute Measles Panel, IgM Antibody and PCR

CPT

86765; 87798

Synonyms

Rubeola

  • Share
  • Print
  • Updated on 03/06/2025

Test Details

Methodology

Chemiluminescence immunoassay (CLIA) and Polymerase Chain Reaction (PCR)

Result Turnaround Time

4 - 6 days

4 - 6 days

Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.

Test Includes

Measles (Rubeola) Antibodies, IgM and Measles (Rubeola), PCR, Swab

Use

This test is used as a guideline-aligned laboratory diagnosis of acute measles virus infection in patients presenting with febrile rash illness and clinically compatible measles symptoms.

Limitations

A negative test does not rule out infection with measles virus. Results should be interpreted in conjunction with clinical finding.

The absence of IgM-class antibodies suggests lack of an acute phase infection with measles virus. However, serology may be negative for IgM-class antibodies in early disease, and results should be interpreted in the context of clinical findings.

Testing for IgM-class antibodies to measles should be limited to patients with clinically compatible disease. Specimens should be collected as soon as possible after the development of rash to maximize the sensitivity of measles RNA detection.

Improperly collected samples may result in false negative results.

PCR assays may be impacted by viral variants and may result in reduced sensitivity or false negative results.

The Measles PCR was developed and its performance characteristics determined by Labcorp. It has not been cleared or approved by the Food and Drug Administration.

Specimen Requirements

Specimen

Serum and throat or NP swab

Volume

1 mL serum and 1 swab

Minimum Volume

0.5 mL serum and 1 swab (Note: This volume does not allow for repeat testing.)

Container

Serum: gel-barrier tube, red-top tube or transfer tube

Swab: Viral Transport Media (VTM) or Universal Transport Media (UTM)

Collection Instructions

Serum: If tube other than a gel-barrier tube is used, transfer serum to a plastic transport tube.

Swab: Throat specimen (preferred): Collect the specimen by swabbing the posterior pharynx. Nasopharyngeal swab: Collect the NP swab using standard techniques.

Stability Requirements

Temperature Period
Room temperatureUnstable
Refrigerated

Serum: 7 days

Swab: 7 days

Frozen

Serum: 6 months

Swab: 14 days

Storage Instructions

Refrigerate.

Causes for Rejection

Improperly submitted specimens; grossly hemolyzed, lipemic and icteric samples; heat-inactivated samples; samples with visible particulate matter or gross bacterial contamination; specimen not received in an approved VTM/UTM; swabs received in Liquid Amies (E-Swabs) or other bacterial swabs; specimens received without a swab; grossly leaking specimens; specimens received outside the stated stability

References

Clinical Overview of Measles. Centers for Disease Control and Prevention website: https://www.cdc.gov/measles/hcp/clinical-overview/index.html#cdc_clinical_overview_test_dia-diagnosis-and-laboratory-testing. Updated July 15, 2024. Accessed October 2024.

LOINC® Map

Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC
160077 Acute Measles Panel REQUEST 160177 Measles IgM, Serum 21503-8
160077 Acute Measles Panel REQUEST 140471 Measles RNA, Swab 91077-8
Order Code160077
Order Code NameAcute Measles Panel
Order LoincREQUEST
Result Code160177
Result Code NameMeasles IgM, Serum
UofM
Result LOINC21503-8
Order Code160077
Order Code NameAcute Measles Panel
Order LoincREQUEST
Result Code140471
Result Code NameMeasles RNA, Swab
UofM
Result LOINC91077-8